A Humanized Neutralizing Antibody Against MERS-CoV Targeting the Receptor-Binding Domain of the Spike Protein

Cell Research - United States
doi 10.1038/cr.2015.113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain

2020English

Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Mutations in the Spike Protein of MERS-CoV Transmitted in Korea Increase Resistance Towards Antibody-Mediated Neutralization

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2018English

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights

2020English

The 2019 Coronavirus (SARS-CoV-2) Surface Protein (Spike) S1 Receptor Binding Domain Undergoes Conformational Change Upon Heparin Binding.

2020English

Inclusion of MERS-spike Protein ELISA in Algorithm to Determine Serologic Evidence of MERS-CoV Infection

Journal of Medical Virology
VirologyInfectious Diseases
2017English

On the Interactions of the Receptor-Binding Domain of SARS-CoV-1 and SARS-CoV-2 Spike Proteins With Monoclonal Antibodies and the Receptor ACE2

2020English

De Novo Design of High-Affinity Antibody Variable Regions (scFv) Against the SARS-CoV-2 Spike Protein

2020English

Optimization of Antigen Dose for a Receptor-Binding Domain-Based Subunit Vaccine Against MERS Coronavirus

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy